[go: up one dir, main page]

WO2001020533A3 - Creation of a database of biochemical data and methods of use - Google Patents

Creation of a database of biochemical data and methods of use Download PDF

Info

Publication number
WO2001020533A3
WO2001020533A3 PCT/US2000/025183 US0025183W WO0120533A3 WO 2001020533 A3 WO2001020533 A3 WO 2001020533A3 US 0025183 W US0025183 W US 0025183W WO 0120533 A3 WO0120533 A3 WO 0120533A3
Authority
WO
WIPO (PCT)
Prior art keywords
blood
patient
biochemicals
concentrations
database
Prior art date
Application number
PCT/US2000/025183
Other languages
French (fr)
Other versions
WO2001020533A2 (en
Inventor
Mark B Chandler
Van S Chandler
Original Assignee
Luminex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luminex Corp filed Critical Luminex Corp
Priority to EP00965004A priority Critical patent/EP1250675A2/en
Priority to AU75799/00A priority patent/AU7579900A/en
Publication of WO2001020533A2 publication Critical patent/WO2001020533A2/en
Publication of WO2001020533A3 publication Critical patent/WO2001020533A3/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

This invention is based on the observation that all diseases may be diagnosed by analysis of at least about 200-300 biochemicals present in a patient's blood. In addition, disease progression may also be predicted from the profile of biochemicals in the blood. This invention takes advantage of rapid automated methods for determining the concentrations of biochemicals in the blood of a patient and compares these concentrations to a database which includes information derived from a multi-year study of approximately 200,000 persons. From the correlations found between biochemical concentrations in the blood and the existence of disease states, this invention permits the diagnosis of a present disease state in the patient and has the capacity to predict the emergence of future disease states in the patient.
PCT/US2000/025183 1999-09-15 2000-09-15 Creation of a database of biochemical data and methods of use WO2001020533A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP00965004A EP1250675A2 (en) 1999-09-15 2000-09-15 Creation of a database of biochemical data and methods of use
AU75799/00A AU7579900A (en) 1999-09-15 2000-09-15 Creation of a database of biochemical data and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15394199P 1999-09-15 1999-09-15
US60/153,941 1999-09-15

Publications (2)

Publication Number Publication Date
WO2001020533A2 WO2001020533A2 (en) 2001-03-22
WO2001020533A3 true WO2001020533A3 (en) 2002-08-15

Family

ID=22549345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/025183 WO2001020533A2 (en) 1999-09-15 2000-09-15 Creation of a database of biochemical data and methods of use

Country Status (3)

Country Link
EP (1) EP1250675A2 (en)
AU (1) AU7579900A (en)
WO (1) WO2001020533A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US9360476B2 (en) 2006-12-19 2016-06-07 Fio Corporation Microfluidic system and method to test for target molecules in a biological sample
US9459200B2 (en) 2008-08-29 2016-10-04 Fio Corporation Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952696A0 (en) * 2002-11-14 2002-11-28 Genomics Research Partners Pty Ltd Status determination
US20040236188A1 (en) * 2003-05-19 2004-11-25 Ge Medical Systems Information Method and apparatus for monitoring using a mathematical model
US7198900B2 (en) * 2003-08-29 2007-04-03 Applera Corporation Multiplex detection compositions, methods, and kits
WO2005088313A1 (en) * 2004-03-11 2005-09-22 Baylor College Of Medicine Method to predict risk of bph progression
US8551763B2 (en) 2007-10-12 2013-10-08 Fio Corporation Flow focusing method and system for forming concentrated volumes of microbeads, and microbeads formed further thereto
US9792809B2 (en) 2008-06-25 2017-10-17 Fio Corporation Bio-threat alert system
CN104374932A (en) 2009-01-13 2015-02-25 Fio公司 A handheld diagnostic test device used with an electronic device and a test cartridge in a rapid diagnostic test
EP2686688B1 (en) 2011-03-17 2019-05-08 Cernostics, Inc. Systems and compositions for diagnosing barrett's esophagus and methods of using the same
CN108073787A (en) * 2017-12-30 2018-05-25 齐鲁工业大学 A kind of method that skin care item are customized based on skin background index
EP4523130A1 (en) 2022-05-10 2025-03-19 Google LLC Summarization with user interface (ui) stream control and actionable information extraction

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002360A1 (en) * 1991-07-16 1993-02-04 Transmed Biotech Incorporated Methods and compositions for simultaneous analysis of multiple analytes
WO1997014028A2 (en) * 1995-10-11 1997-04-17 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US5687716A (en) * 1995-11-15 1997-11-18 Kaufmann; Peter Selective differentiating diagnostic process based on broad data bases
WO1998035609A1 (en) * 1997-02-14 1998-08-20 Biomar International, Inc. A system for predicting future health
WO1999019515A1 (en) * 1997-10-14 1999-04-22 Luminex Corporation Precision fluorescently dyed particles and methods of making and using same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002360A1 (en) * 1991-07-16 1993-02-04 Transmed Biotech Incorporated Methods and compositions for simultaneous analysis of multiple analytes
WO1997014028A2 (en) * 1995-10-11 1997-04-17 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US5687716A (en) * 1995-11-15 1997-11-18 Kaufmann; Peter Selective differentiating diagnostic process based on broad data bases
WO1998035609A1 (en) * 1997-02-14 1998-08-20 Biomar International, Inc. A system for predicting future health
WO1999019515A1 (en) * 1997-10-14 1999-04-22 Luminex Corporation Precision fluorescently dyed particles and methods of making and using same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US8597899B2 (en) 2006-05-17 2013-12-03 Cernostics, Inc. Method for automated tissue analysis
US9360476B2 (en) 2006-12-19 2016-06-07 Fio Corporation Microfluidic system and method to test for target molecules in a biological sample
US9459200B2 (en) 2008-08-29 2016-10-04 Fio Corporation Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples

Also Published As

Publication number Publication date
AU7579900A (en) 2001-04-17
EP1250675A2 (en) 2002-10-23
WO2001020533A2 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
WO2001020533A3 (en) Creation of a database of biochemical data and methods of use
WO2005023086A3 (en) Systems, methods, and computer program products for analysis of vessel attributes for diagnosis, disease staging, and surgical planning
WO2004020968A3 (en) Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease
WO2001069513A3 (en) A system and method for obtaining, processing and evaluating patient information for diagnosing disease and selecting treatment
Sandsmark Clinical outcomes after traumatic brain injury
ATE283485T1 (en) METHOD FOR DIAGNOSIS AND CHARACTERIZATION OF STROKE
EP0962878A3 (en) Reflex algorithm for early and cost effective diagnosis of myocardial infarctions suitable for automated diagnostic platforms
WO2001040517A3 (en) Evaluating and predicting clinical outcomes by gene expression analysis
WO1998027226B1 (en) Method for determining the prognosis of a patient with a neurological disease
DK1421215T3 (en) Methods for evaluating pathological conditions using extracellular RNA
EP1418523A3 (en) Diagnosis support system for diabetes
EP1102196A3 (en) Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes therof
WO2003060750A3 (en) A system for supporting clinical decision-making
NO20050186D0 (en) Oligosaccharide Biomarkers for Mucopolysaccharides and Other Related Disorders
WO2002098280A3 (en) Method for detecting infectious agents using computer controlled automated image analysis
DE60333608D1 (en) Biomarker for the diagnosis of Alzheimer's
WO2001016859A3 (en) System and method for genomic and proteomic animal disease assessment via expression profile comparison
Boeker et al. Diagnosing schizophrenia from activity records using hidden Markov model parameters
WO2006036960A3 (en) System and method for clinically assessing motor function
WO2000025138A3 (en) Methods of diagnosing or prognosing alzheimer's disease
Baltes et al. The Berlin Aging Study: Aging from 70 to 100
Prasad et al. Psychogeriatric patients-a sociodemographic and clinical profile
WO2006003414A3 (en) Biomarkers of alzheimer's disease
WO2002096266A3 (en) Method and system for optically performing an assay to determine a medical condition
Clark Modern concepts of epidemiology

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000965004

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000965004

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP